BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35779530)

  • 1. circEPSTI1 promotes tumor progression and cisplatin resistance via upregulating MSH2 in cervical cancer.
    Wu P; Qin J; Liu L; Tan W; Lei L; Zhu J
    Aging (Albany NY); 2022 Jul; 14(13):5406-5416. PubMed ID: 35779530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circEPSTI1 accelerates cervical cancer progression via miR-375/409-3P/515-5p-SLC7A11 axis.
    Wu P; Li C; Ye DM; Yu K; Li Y; Tang H; Xu G; Yi S; Zhang Z
    Aging (Albany NY); 2021 Feb; 13(3):4663-4673. PubMed ID: 33534779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. circEPSTI1 Acts as a ceRNA to Regulate the Progression of Osteosarcoma.
    Tan X; Tan D; Li H; Lin Y; Wen Z; Zeng C
    Curr Cancer Drug Targets; 2020; 20(4):288-294. PubMed ID: 31702512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circEPSTI1 regulates ovarian cancer progression via decoying miR-942.
    Xie J; Wang S; Li G; Zhao X; Jiang F; Liu J; Tan W
    J Cell Mol Med; 2019 May; 23(5):3597-3602. PubMed ID: 30887698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of long noncoding RNA NCK1-AS1 increases chemosensitivity to cisplatin in cervical cancer.
    Zhang WY; Liu YJ; He Y; Chen P
    J Cell Physiol; 2019 Apr; 234(4):4302-4313. PubMed ID: 30221354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression.
    Chen B; Wei W; Huang X; Xie X; Kong Y; Dai D; Yang L; Wang J; Tang H; Xie X
    Theranostics; 2018; 8(14):4003-4015. PubMed ID: 30083277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway.
    Wang J; Jiang C; Li N; Wang F; Xu Y; Shen Z; Yang L; Li Z; He C
    Cell Death Dis; 2020 Aug; 11(8):682. PubMed ID: 32826876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA circRNA_101996 promoted cervical cancer development by regulating miR-1236-3p/TRIM37 axis.
    Song TF; Xu AL; Chen XH; Gao JY; Gao F; Kong XC
    Kaohsiung J Med Sci; 2021 Jul; 37(7):547-561. PubMed ID: 33728810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircAGFG1 promotes cervical cancer progression via miR-370-3p/RAF1 signaling.
    Wu F; Zhou J
    BMC Cancer; 2019 Nov; 19(1):1067. PubMed ID: 31703640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
    Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
    BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel circCLK3/miR-320a/FoxM1 axis promotes cervical cancer progression.
    Hong H; Zhu H; Zhao S; Wang K; Zhang N; Tian Y; Li Y; Wang Y; Lv X; Wei T; Liu Y; Fan S; Liu Y; Li Y; Cai A; Jin S; Qin Q; Li H
    Cell Death Dis; 2019 Dec; 10(12):950. PubMed ID: 31831728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIF4A3-regulated circ_0087429 can reverse EMT and inhibit the progression of cervical cancer via miR-5003-3p-dependent upregulation of OGN expression.
    Yang M; Hu H; Wu S; Ding J; Yin B; Huang B; Li F; Guo X; Han L
    J Exp Clin Cancer Res; 2022 May; 41(1):165. PubMed ID: 35513835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CircDOCK1 promotes the tumorigenesis and cisplatin resistance of osteogenic sarcoma via the miR-339-3p/IGF1R axis.
    Li S; Liu F; Zheng K; Wang W; Qiu E; Pei Y; Wang S; Zhang J; Zhang X
    Mol Cancer; 2021 Dec; 20(1):161. PubMed ID: 34876132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0000388 Exerts Oncogenic Function in Cervical Cancer Cells by Regulating miR-337-3p/
    Meng QH; Li Y; Kong C; Gao XM; Jiang XJ
    Cancer Biother Radiopharm; 2021 Feb; 36(1):58-69. PubMed ID: 32119786
    [No Abstract]   [Full Text] [Related]  

  • 15. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
    Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
    Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of circEPSTI1 represses the proliferation and invasion of non-small cell lung cancer by inhibiting TRIM24 via miR-1248 upregulation.
    Yang T; Li M; Li H; Shi P; Liu J; Chen M
    Biochem Biophys Res Commun; 2020 Sep; 530(1):348-354. PubMed ID: 32828310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircEPSTI1 Promotes the Progression of Non-Small Cell Lung Cancer Through miR-145/HMGB3 Axis.
    Xie Y; Wang L; Yang D
    Cancer Manag Res; 2020; 12():6827-6836. PubMed ID: 32801908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis.
    Ma H; Tian T; Liu X; Xia M; Chen C; Mai L; Xie S; Yu L
    Biomed Pharmacother; 2019 Oct; 118():109311. PubMed ID: 31545253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular RNA RBM33 contributes to cervical cancer progression via modulation of the miR-758-3p/PUM2 axis.
    Ding Y; Yuan X; Gu W
    J Mol Histol; 2021 Apr; 52(2):173-185. PubMed ID: 33398465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of hsa_circ_0009035 Suppresses Cervical Cancer Progression and Enhances Radiosensitivity through MicroRNA 889-3p-Dependent Regulation of HOXB7.
    Zhao X; Dong W; Luo G; Xie J; Liu J; Yu F
    Mol Cell Biol; 2021 May; 41(6):e0063120. PubMed ID: 33782039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.